Christin E Burd
Christin E Burd
Departments of Molecular Genetics, Cancer Biology and Genetics, The Ohio State University
Verified email at - Homepage
Cited by
Cited by
Circular RNAs are abundant, conserved, and associated with ALU repeats
WR Jeck, JA Sorrentino, K Wang, MK Slevin, CE Burd, J Liu, WF Marzluff, ...
Rna 19 (2), 141-157, 2013
Expression of linear and novel circular forms of an INK4/ARF-associated non-coding RNA correlates with atherosclerosis risk
CE Burd, WR Jeck, Y Liu, HK Sanoff, Z Wang, NE Sharpless
PLoS Genet 6 (12), e1001233, 2010
Expression of p16INK4a in peripheral blood T‐cells is a biomarker of human aging
Y Liu, HK Sanoff, H Cho, CE Burd, C Torrice, JG Ibrahim, NE Thomas, ...
Aging cell 8 (4), 439-448, 2009
INK4/ARF transcript expression is associated with chromosome 9p21 variants linked to atherosclerosis
Y Liu, HK Sanoff, H Cho, CE Burd, C Torrice, KL Mohlke, JG Ibrahim, ...
PloS one 4 (4), e5027, 2009
Monitoring tumorigenesis and senescence in vivo with a p16INK4a-luciferase model
CE Burd, JA Sorrentino, KS Clark, DB Darr, J Krishnamurthy, AM Deal, ...
Cell 152 (1-2), 340-351, 2013
The Xenoestrogen Bisphenol A Induces Inappropriate Androgen Receptor Activation and Mitogenesis in Prostatic Adenocarcinoma Cells 1 This work was supported by NIH Training …
YB Wetherill, CE Petre, KR Monk, A Puga, KE Knudsen
Molecular cancer therapeutics 1 (7), 515-524, 2002
The molecular balancing act of p16INK4a in cancer and aging
KM LaPak, CE Burd
Molecular Cancer Research 12 (2), 167-183, 2014
Fisetin is a senotherapeutic that extends health and lifespan
MJ Yousefzadeh, Y Zhu, SJ McGowan, L Angelini, ...
EBioMedicine 36, 18-28, 2018
Cyclin D1: mechanism and consequence of androgen receptor co-repressor activity
CE Petre, YB Wetherill, M Danielsen, KE Knudsen
Journal of Biological Chemistry 277 (3), 2207-2215, 2002
Liposomal daunorubicin as treatment for Kaposi’s sarcoma
CE Petre, DP Dittmer
International journal of nanomedicine 2 (3), 277, 2007
Cyclin D1b variant influences prostate cancer growth through aberrant androgen receptor regulation
CJ Burd, CE Petre, LM Morey, Y Wang, MP Revelo, CA Haiman, S Lu, ...
Proceedings of the National Academy of Sciences 103 (7), 2190-2195, 2006
An oncogenic Ezh2 mutation induces tumors through global redistribution of histone 3 lysine 27 trimethylation
GP Souroullas, WR Jeck, JS Parker, JM Simon, JY Liu, J Paulk, J Xiong, ...
Nature medicine 22 (6), 632, 2016
Functional p53 signaling in Kaposi's sarcoma-associated herpesvirus lymphomas: implications for therapy
CE Petre, SH Sin, DP Dittmer
Journal of virology 81 (4), 1912-1922, 2007
Mutation-specific RAS oncogenicity explains NRAS codon 61 selection in melanoma
CE Burd, W Liu, MV Huynh, MA Waqas, JE Gillahan, KS Clark, K Fu, ...
Cancer discovery 4 (12), 1418-1429, 2014
Differential requirement of SWI/SNF for androgen receptor activity
TW Marshall, KA Link, CE Petre-Draviam, KE Knudsen
Journal of Biological Chemistry 278 (33), 30605-30613, 2003
Cyclin D1 binding to the androgen receptor (AR) NH2-terminal domain inhibits activation function 2 association and reveals dual roles for AR corepression
CJ Burd, CE Petre, H Moghadam, EM Wilson, KE Knudsen
Molecular Endocrinology 19 (3), 607-20, 2005
Specificity of cyclin D1 for androgen receptor regulation
CE Petre-Draviam, SL Cook, CJ Burd, TW Marshall, YB Wetherill, ...
Cancer research 63 (16), 4903-4913, 2003
A central domain of cyclin D1 mediates nuclear receptor corepressor activity
CE Petre-Draviam, EB Williams, CJ Burd, A Gladden, H Moghadam, ...
Oncogene 24 (3), 431-444, 2005
Distinct p53, p53: LANA, and LANA complexes in Kaposi's sarcoma-associated herpesvirus lymphomas
W Chen, IB Hilton, MR Staudt, CE Burd, DP Dittmer
Journal of virology 84 (8), 3898-3908, 2010
p16INK4a reporter mice reveal age-promoting effects of environmental toxicants
JA Sorrentino, J Krishnamurthy, S Tilley, JG Alb, CE Burd, NE Sharpless
The Journal of clinical investigation 124 (1), 169-173, 2014
The system can't perform the operation now. Try again later.
Articles 1–20